TY - JOUR AU - Morris, S. W. AU - Kirstein, M. N. AU - Valentine, M. B. AU - Dittmer, K. G. AU - Shapiro, D. N. AU - Saltman, D. L. PY - 1994 DA - 1994// TI - Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin’s lymphoma JO - Science VL - 263 UR - https://doi.org/10.1126/science.8122112 DO - 10.1126/science.8122112 ID - Morris1994 ER - TY - JOUR AU - Soda, M. AU - Choi, Y. L. AU - Enomoto, M. AU - Takada, S. AU - Yamashita, Y. AU - Ishikawa, S. PY - 2007 DA - 2007// TI - Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer JO - Nature VL - 448 UR - https://doi.org/10.1038/nature05945 DO - 10.1038/nature05945 ID - Soda2007 ER - TY - JOUR AU - Wong, D. W. -. S. AU - Leung, E. L. -. H. AU - So, K. K. -. T. AU - Tam, I. Y. -. S. AU - Sihoe, A. D. -. L. AU - Cheng, L. -. C. PY - 2009 DA - 2009// TI - The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS JO - Cancer VL - 115 UR - https://doi.org/10.1002/cncr.24181 DO - 10.1002/cncr.24181 ID - Wong2009 ER - TY - JOUR AU - Takeuchi, K. AU - Choi, Y. L. AU - Togashi, Y. AU - Soda, M. AU - Hatano, S. AU - Inamura, K. PY - 2009 DA - 2009// TI - KIF5B-ALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALK-positive lung cancer JO - Clin Cancer Res VL - 15 UR - https://doi.org/10.1158/1078-0432.CCR-08-3248 DO - 10.1158/1078-0432.CCR-08-3248 ID - Takeuchi2009 ER - TY - JOUR AU - Rikova, K. AU - Guo, A. AU - Zeng, Q. AU - Possemato, A. AU - Yu, J. AU - Haack, H. PY - 2007 DA - 2007// TI - Global Survey of Phosphotyrosine Signaling Identifies Oncogenic Kinases in Lung Cancer JO - Cell VL - 131 UR - https://doi.org/10.1016/j.cell.2007.11.025 DO - 10.1016/j.cell.2007.11.025 ID - Rikova2007 ER - TY - JOUR AU - Roskoski, R. PY - 2013 DA - 2013// TI - Anaplastic lymphoma kinase (ALK): structure, oncogenic activation, and pharmacological inhibition JO - Pharmacol Res VL - 68 UR - https://doi.org/10.1016/j.phrs.2012.11.007 DO - 10.1016/j.phrs.2012.11.007 ID - Roskoski2013 ER - TY - JOUR AU - Mossé, Y. P. AU - Wood, A. AU - Maris, J. M. PY - 2009 DA - 2009// TI - Inhibition of ALK signaling for cancer therapy JO - Clin Cancer Res VL - 15 UR - https://doi.org/10.1158/1078-0432.CCR-08-2762 DO - 10.1158/1078-0432.CCR-08-2762 ID - Mossé2009 ER - TY - JOUR AU - Gaughan, E. M. AU - Costa, D. B. PY - 2011 DA - 2011// TI - Genotype-driven therapies for non-small cell lung cancer: focus on EGFR, KRAS and ALK gene abnormalities JO - Ther Adv Med Oncol VL - 3 UR - https://doi.org/10.1177/1758834010397569 DO - 10.1177/1758834010397569 ID - Gaughan2011 ER - TY - JOUR AU - Shaw, A. T. AU - Yeap, B. Y. AU - Mino-Kenudson, M. AU - Digumarthy, S. R. AU - Costa, D. B. AU - Heist, R. S. PY - 2009 DA - 2009// TI - Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2009.22.6993 DO - 10.1200/JCO.2009.22.6993 ID - Shaw2009 ER - TY - JOUR AU - McKeage, K. PY - 2014 DA - 2014// TI - Alectinib: A Review of Its Use in Advanced ALK-Rearranged Non-Small Cell Lung Cancer JO - Drugs VL - 75 UR - https://doi.org/10.1007/s40265-014-0329-y DO - 10.1007/s40265-014-0329-y ID - McKeage2014 ER - TY - JOUR AU - Wu, J. AU - Savooji, J. AU - Liu, D. PY - 2016 DA - 2016// TI - Second- and third-generation ALK inhibitors for non-small cell lung cancer JO - J Hematol Oncol VL - 9 UR - https://doi.org/10.1186/s13045-016-0251-8 DO - 10.1186/s13045-016-0251-8 ID - Wu2016 ER - TY - JOUR AU - Jung, S. -. H. AU - Sohn, I. PY - 2014 DA - 2014// TI - Statistical Issues in the Design and Analysis of nCounter Projects JO - Cancer Inform VL - 13 UR - https://doi.org/10.4137/CIN.S16343 DO - 10.4137/CIN.S16343 ID - Jung2014 ER - TY - JOUR AU - Lira, M. E. AU - Kim, T. M. AU - Huang, D. AU - Deng, S. AU - Koh, Y. AU - Jang, B. PY - 2013 DA - 2013// TI - Multiplexed gene expression and fusion transcript analysis to detect ALK fusions in lung cancer JO - J Mol Diagn VL - 15 UR - https://doi.org/10.1016/j.jmoldx.2012.08.006 DO - 10.1016/j.jmoldx.2012.08.006 ID - Lira2013 ER - TY - JOUR AU - Kulkarni, M. M. PY - 2011 DA - 2011// TI - Digital multiplexed gene expression analysis using the NanoString nCounter system JO - Curr Protoc Mol Biol VL - 25 ID - Kulkarni2011 ER - TY - JOUR AU - Yamane, L. S. AU - Scapulatempo-Neto, C. AU - Alvarenga, L. AU - Oliveira, C. Z. AU - Berardinelli, G. N. AU - Almodova, E. PY - 2014 DA - 2014// TI - KRAS and BRAF mutations and MSI status in precursor lesions of colorectal cancer detected by colonoscopy JO - Oncol Rep VL - 32 ID - Yamane2014 ER - TY - JOUR AU - Becker, A. P. AU - Scapulatempo-Neto, C. AU - Carloni, A. C. AU - Paulino, A. AU - Sheren, J. AU - Aisner, D. L. PY - 2015 DA - 2015// TI - KIAA1549: BRAF Gene Fusion and FGFR1 Hotspot Mutations Are Prognostic Factors in Pilocytic Astrocytomas JO - J Neuropathol Exp Neurol VL - 74 UR - https://doi.org/10.1097/NEN.0000000000000213 DO - 10.1097/NEN.0000000000000213 ID - Becker2015 ER - TY - JOUR AU - Reis-Filho, J. S. AU - Pinheiro, C. AU - Lambros, M. B. K. AU - Milanezi, F. AU - Carvalho, S. AU - Savage, K. PY - 2006 DA - 2006// TI - EGFR amplification and lack of activating mutations in metaplastic breast carcinomas JO - J Pathol VL - 209 UR - https://doi.org/10.1002/path.2004 DO - 10.1002/path.2004 ID - Reis-Filho2006 ER - TY - JOUR AU - Camidge, D. R. AU - Kono, S. A. AU - Flacco, A. AU - Tan, A. -. C. AU - Doebele, R. C. AU - Zhou, Q. PY - 2010 DA - 2010// TI - Optimizing the detection of lung cancer patients harboring anaplastic lymphoma kinase (ALK) gene rearrangements potentially suitable for ALK inhibitor treatment JO - Clin Cancer Res VL - 16 UR - https://doi.org/10.1158/1078-0432.CCR-10-0851 DO - 10.1158/1078-0432.CCR-10-0851 ID - Camidge2010 ER - TY - JOUR AU - Kwak, E. L. AU - Bang, Y. -. J. AU - Camidge, D. R. AU - Shaw, A. T. AU - Solomon, B. AU - Maki, R. G. PY - 2010 DA - 2010// TI - Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer JO - N Engl J Med VL - 363 UR - https://doi.org/10.1056/NEJMoa1006448 DO - 10.1056/NEJMoa1006448 ID - Kwak2010 ER - TY - JOUR AU - Wynes, M. W. AU - Sholl, L. M. AU - Dietel, M. AU - Schuuring, E. AU - Tsao, M. S. AU - Yatabe, Y. PY - 2014 DA - 2014// TI - An international interpretation study using the ALK IHC antibody D5F3 and a sensitive detection kit demonstrates high concordance between ALK IHC and ALK FISH and between evaluators JO - J Thorac Oncol VL - 9 UR - https://doi.org/10.1097/JTO.0000000000000115 DO - 10.1097/JTO.0000000000000115 ID - Wynes2014 ER - TY - JOUR AU - Wilson, F. H. AU - Johannessen, C. M. AU - Piccioni, F. AU - Tamayo, P. AU - Kim, J. W. AU - Allen, E. M. PY - 2015 DA - 2015// TI - A functional landscape of resistance to ALK inhibition in lung cancer JO - Cancer Cell VL - 27 UR - https://doi.org/10.1016/j.ccell.2015.02.005 DO - 10.1016/j.ccell.2015.02.005 ID - Wilson2015 ER - TY - JOUR AU - Heuckmann, J. M. AU - Balke-Want, H. AU - Malchers, F. AU - Peifer, M. AU - Sos, M. L. AU - Koker, M. PY - 2012 DA - 2012// TI - Differential protein stability and ALK inhibitor sensitivity of EML4-ALK fusion variants JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-11-3260 DO - 10.1158/1078-0432.CCR-11-3260 ID - Heuckmann2012 ER - TY - JOUR AU - Crystal, A. S. AU - Shaw, A. T. PY - 2012 DA - 2012// TI - Variants on a theme: a biomarker of crizotinib response in ALK-positive non-small cell lung cancer? JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-12-1952 DO - 10.1158/1078-0432.CCR-12-1952 ID - Crystal2012 ER - TY - JOUR AU - Rogers, T. -. M. AU - Arnau, G. M. AU - Ryland, G. L. AU - Huang, S. AU - Lira, M. E. AU - Emmanuel, Y. PY - 2017 DA - 2017// TI - Multiplexed transcriptome analysis to detect ALK, ROS1 and RET rearrangements in lung cancer JO - Sci Rep VL - 7 UR - https://doi.org/10.1038/srep42259 DO - 10.1038/srep42259 ID - Rogers2017 ER - TY - JOUR AU - Ali, S. M. AU - Hensing, T. AU - Schrock, A. B. AU - Allen, J. AU - Sanford, E. AU - Gowen, K. PY - 2016 DA - 2016// TI - Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization JO - Oncologist VL - 21 UR - https://doi.org/10.1634/theoncologist.2015-0497 DO - 10.1634/theoncologist.2015-0497 ID - Ali2016 ER - TY - JOUR AU - Dagogo-Jack, I. AU - Shaw, A. T. PY - 2016 DA - 2016// TI - Screening for ALK Rearrangements in Lung Cancer: Time for a New Generation of Diagnostics? JO - Oncologist VL - 21 UR - https://doi.org/10.1634/theoncologist.2016-0179 DO - 10.1634/theoncologist.2016-0179 ID - Dagogo-Jack2016 ER - TY - JOUR AU - Cesano, A. PY - 2015 DA - 2015// TI - nCounter(®) PanCancer Immune Profiling Panel (NanoString Technologies, Inc., Seattle, WA) JO - J Immunother Cancer VL - 3 UR - https://doi.org/10.1186/s40425-015-0088-7 DO - 10.1186/s40425-015-0088-7 ID - Cesano2015 ER -